 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Elan Corporation, plc
 |
Elan Corporation, plc |
 |
 |
 |
NEWS FROM THE WIRES |
 |
BP , Shell shrug off any windfall tax fears Aug 08 2001 12:42 AM PDT
Chemicals, techs dent eurostocks; Bayer dives Aug 08 2001 12:35 AM PDT
UK's FTSE 100 retreats as banks, telcos weaken Aug 08 2001 12:33 AM PDT
SkyePharma buys stake in Canadian drug firm Jul 31 2001 11:06 PM PDT
SkyePharma buys stake in Canadian drug firm Jul 31 2001 11:06 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Elan dashingly develops drugs and drug-delivery systems through its subsidiaries. Business units include Elan Pharmaceuticals, which focuses on neurology, pain management, and cardiology. The subsidiary also markets Elan's products. Its Elan Pharmaceutical Technologies unit designs oral and transdermal (patch) delivery systems, while Elan Pharmaceutical Operations is the company's manufacturing arm. Products in development include a vaccine for amyloid plaques characteristic of Alzheimer's disease, along with treatments for epilepsy, Parkinson's disease, and hypertension. The firm bought Dura Pharmaceuticals to add to its US marketing force.
COMPETITION |
 |
ALZA Corporation (dossier)
Neurocrine Biosciences, Inc. (NBIX)
R.P. Scherer Corporation (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 1,302.00
1-Yr. Sales Growth: 29.2%
Employees: 4,472
Revenue per employee: $291,144.90
KEY PEOPLE |
 |
Donal J. Geaney
CEO
CONTACT INFO |
 |
Lincoln House, Lincoln Place
Dublin 2, Ireland
Phone: 353-1-709-4000
Fax: 353-1-662-4949
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |